Found 4 results
Filters: Author is S.F. Xu  [Clear All Filters]
L. Yang, Wang, L. J., Shi, G. L., Ni, L., Song, C. X., Zhang, Z. X., and Xu, S. F., Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer, vol. 9, pp. 750-755, 2010.
Ainsworth PJ, Surh LC and Coulter-Mackie MB (1991). Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. Nucleic Acids Res. 19: 405-406. PMid:2014179 PMCid:333615   Bidwell JL, Bidwell EA, Savage DA, Middleton D, et al. (1988). A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 45: 640-646. PMid:2894727   Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, et al. (1987). The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518. PMid:2443855   Cantú de León D, Perez-Montiel D, Villavicencio V, Garcia CA, et al. (2009). High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 9: 48. PMid:19196481 PMCid:2653544   Chen WQ, Zhang SW and Kong LS (2008). Cancer mortality report of 34 registries in China, 2004. Bull. Chin. Cancer 17: 913-916.   Dalva K and Beksac M (2007). HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the Luminex technology. Methods Mol. Med. 134: 61-69. PMid:17666743   Davis RW, Thomas M, Cameron J, St John TP, et al. (1980). Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol. 65: 404-411.   Dorak MT, Oguz FS, Yalman N, Diler AS, et al. (2002). A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk. Res. 26: 651-656.   Ferlay J, Autier P, Boniol M, Heanue M, et al. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18: 581-592. PMid:17287242   Gresner P, Gromadzinska J and Wasowicz W (2007). Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57: 1-25. PMid:17337085   Haghpanah V, Khalooghi K, Adabi K, Amiri P, et al. (2009). Associations between HLA-C alleles and papillary thyroid carcinoma. Cancer Biomark. 5: 19-22. PMid:19242058   Hoppe B and Salama A (2007). Sequencing-based typing of HLA. Methods Mol. Med. 134: 71-80. PMid:17666744   Jemal A, Siegel R, Ward E, Hao Y, et al. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59: 225-249. PMid:19474385   Kiyohara C, Takayama K and Nakanishi Y (2006). Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54: 267-283. PMid:16982113   Kübler K, Arndt PF, Wardelmann E, Krebs D, et al. (2006). HLA-class II haplotype associations with ovarian cancer. Int. J. Cancer 119: 2980-2985. PMid:17016821   Madeleine MM, Johnson LG, Smith AG, Hansen JA, et al. (2008). Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res. 68: 3532-3539. PMid:18451182 PMCid:2662593   Marsh SG (2003). HLA nomenclature and the IMGT/HLA sequence database. Novartis Found. Symp. 254: 165-173. PMid:14712937   Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. PMid:3344216 PMCid:334765   Mundhada S, Luthra R and Cano P (2004). Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11). BMC Cancer 4: 25. PMid:15202948 PMCid:441382   Olerup O and Zetterquist H (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235. PMid:1357775   Parkin DM, Bray F, Ferlay J and Pisani P (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108. PMid:15761078   Quintero E, Pizarro MA, Rodrigo L, Pique JM, et al. (2005). Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 10: 12-21. PMid:15691311   Schiff MA, Apple RJ, Lin P, Nelson JL, et al. (2005). HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum. Immunol. 66: 1050-1056. PMid:16386646   Terasaki PI and McClelland JD (1964). Microdroplet assay of human serum cytotoxins. Nature 204: 998-1000. PMid:14248725   Tokumoto H (1998). Analysis of HLA-DRB1-related alleles in Japanese patients with lung cancer - relationship to genetic susceptibility and resistance to lung cancer. J. Cancer Res. Clin. Oncol. 124: 511-516. PMid:9808426   Wu MS, Hsieh RP, Huang SP, Chang YT, et al. (2002). Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn. J. Cancer Res. 93: 404-410. PMid:11985790   Wu Y, Liu B, Lin W, Xu Y, et al. (2007). Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum. Immunol. 68: 192-200. PMid:17349874   Yari F, Sobhani M, Sabaghi F, Zaman-Vaziri M, et al. (2008). Frequencies of HLA-DRB1 in Iranian normal population and in patients with acute lymphoblastic leukemia. Arch. Med. Res. 39: 205-208. PMid:18164964   Yoshimura C, Nomura S, Yamaoka M, Ohtani T, et al. (2000). Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer. Cancer Lett. 152: 87-95.   Young NT and Darke C (1993). Allelic typing of the HLA-DR4 group by polymerase chain reaction-single-strand conformation polymorphism analysis. Hum. Immunol. 37: 69-74.   Zhang SW, Chen WQ and Lei ZI (2008). A report of cancer incidence from 37 cancer registries in China, 2004. Bull. Chin. Cancer 17: 909-912.
L. Yang, Shi, G. L., Song, C. X., and Xu, S. F., Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China, vol. 9, pp. 765-771, 2010.
Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, et al. (2000). Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol. Immunother. 49: 63-70. PMid:10823415   Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, et al. (2004). Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-kinase and Syk-mediated pathways. J. Biol. Chem. 279: 10883-10891. PMid:14699155   Cai Z, Chen Q, Chen J, Lu Y, et al. (2009). Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia 11: 228-236. PMid:19242604 PMCid:2647725   Carr MW, Roth SJ, Luther E, Rose SS, et al. (1994). Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. U. S. A. 91: 3652-3656. PMid:8170963 PMCid:43639   Charo IF and Ransohoff RM (2006). The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354: 610-621. PMid:16467548   Davis RW, Thomas M, Cameron J, St John TP, et al. (1980). Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol. 65: 404-411.   Distler O, Pap T, Kowal-Bielecka O, Meyringer R, et al. (2001). Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum. 44: 2665-2678.<2665::AID-ART446>3.0.CO;2-S   Franco-Marina F, Villalba CJ and Corcho-Berdugo A (2006). Role of active and passive smoking on lung cancer etiology in Mexico City. Salud Publica Mex. 48 (Suppl 1): S75-S82. PMid:17684692   Gu D, Kelly TN, Wu X, Chen J, et al. (2009). Mortality attributable to smoking in China. N. Engl. J. Med. 360: 150-159. PMid:19129528   Jemal A, Siegel R, Ward E, Hao Y, et al. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58: 71-96. PMid:18287387   Jiang Y, Beller DI, Frendl G and Graves DT (1992). Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148: 2423-2428. PMid:1348518   Jockel KH, Ahrens W, Jahn I, Pohlabeln H, et al. (1998). Occupational risk factors for lung cancer: a case-control study in West Germany. Int. J. Epidemiol. 27: 549-560. PMid:9758106   Lee YW, Eum SY, Chen KC, Hennig B, et al. (2004). Gene expression profile in interleukin-4-stimulated human vascular endothelial cells. Mol. Med. 10: 19-27. PMid:15502879 PMCid:1431351   Mackay CR (1997). Chemokines: what chemokine is that? Curr. Biol. 7: R384-R386.   Manome Y, Wen PY, Hershowitz A, Tanaka T, et al. (1995). Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41: 227-235. PMid:7489565   Matsushima K, Larsen CG, DuBois GC and Oppenheim JJ (1989). Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169: 1485-1490. PMid:2926331   Mestdagt M, Polette M, Buttice G, Noel A, et al. (2006). Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells. Int. J. Cancer 118: 35-42. PMid:16003740 PMCid:2965755   Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. PMid:3344216 PMCid:334765   Neuberger JS, Mahnken JD, Mayo MS and Field RW (2006). Risk factors for lung cancer in Iowa women: implications for prevention. Cancer Detect. Prev. 30: 158-167. PMid:16581199 PMCid:1876736   Rollins BJ and Sunday ME (1991). Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell Biol. 11: 3125-3131. PMid:2038321 PMCid:360158   Rollins BJ, Walz A and Baggiolini M (1991a). Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78: 1112-1116. PMid:1868242   Rollins BJ, Morton CC, Ledbetter DH, Eddy RL Jr, et al. (1991b). Assignment of the human small inducible cytokine A2 gene, SCYA2 (encoding JE or MCP-1), to 17q11.2-12: evolutionary relatedness of cytokines clustered at the same locus. Genomics 10: 489-492.   Rovin BH, Lu L and Saxena R (1999). A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 259: 344-348. PMid:10362511   Vázquez-Lavista LG, Lima G, Gabilondo F and Llorente L (2009). Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology 74: 414-418. PMid:19646633   Visbal AL, Williams BA, Nichols FC III, Marks RS, et al. (2004). Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann. Thorac. Surg. 78: 209-215. PMid:15223430   Walter S, Bottazzi B, Govoni D, Colotta F, et al. (1991). Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 49: 431-435. PMid:1655661   Yang L, Parkin DM, Li LD, Chen YD, et al. (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 90: 2157-2166. PMid:15150609 PMCid:2409509